Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis.
Sanjay DhawanAndrew S VenteicherWilliam E ButlerBob S CarterClark C ChenPublished in: Journal of neuro-oncology (2021)
Our meta-analysis suggests that morbidity risk in needle biopsy is non-linearly associated with the number of samples taken. There was no association between the number of biopsies taken, and diagnostic yield or mortality.